Swiss Cancer Institute

This study is testing if terbinafine, a common antifungal medication, can help control prostate cancer that has started to return after initial treatment. It aims to see if the drug can slow the rise of a key blood marker (PSA) and potentially delay the need for stronger hormone …

This study is testing whether combining an older chemotherapy drug (gemcitabine) with a newer two-target drug (ivonescimab) can help control advanced non-small cell lung cancer that has gotten worse despite standard treatment. It will involve about 47 adults whose cancer has prog…

This study is testing whether adding magnesium supplements to standard chemo-immunotherapy helps people with advanced non-small cell lung cancer. Magnesium is important for immune function, and chemotherapy often lowers magnesium levels. Researchers will randomly give 230 partici…

This study is for people 70 and older with advanced lung cancer who are too frail for standard chemotherapy. It compares two approaches: a lower-dose chemotherapy combined with an immunotherapy drug (cemiplimab) versus the immunotherapy drug alone. The goal is to find a treatment…